A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Volunteers.

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2010

At a glance

  • Drugs GS 9411 (Primary)
  • Indications Bronchiectasis; Chronic obstructive pulmonary disease; Cystic fibrosis
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Mar 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
    • 11 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Feb 2010 Planned end date changed from Dec 2009 to Feb 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top